Sandra L. McGuigan, MD, MBA

Board-certified medical oncologist and nuclear medicine physician with over 20 years of hands-on experience in medical oncology and nuclear medicine and 15 years in the pharma industry. Her expertise spans various domains, including clinical development, regulatory affairs, safety, and medical affairs. Orchestrated successful product launches across diverse therapeutic areas including immunotherapies, targeted therapies, and cellular therapies. 

As a medical affairs expert, she has collaborated with healthcare professionals, patients, and payers to optimize treatment outcomes. Her deep understanding of trial design, patient recruitment, and data analysis has been instrumental in bringing novel treatments to patients.